Survey on good practices in handling nanoparticles. - Survey in 37 companies in Netherlands- Paul Borm, Remko Houba, and F...
Current survey of use of Nanomaterials - study questions <ul><li>Use of nanomaterials in NL and number of exposed workers...
122 companies approached 60 companies relevant for survey 37 companies participated (62%) 49 no nanomaterials 8 no applica...
 
Number of exposed workers <ul><li>37 companies </li></ul><ul><ul><li>41.000 employees </li></ul></ul><ul><ul><li>Currently...
Main type of nanomaterials <ul><li>Nanosilver </li></ul><ul><li>Metal-oxides (Al, Fe, Ti, Sn, Zn, Sb, Ce) </li></ul><ul><l...
Risk assessment within companies <ul><li>34 (92%) specific risk-assessment for nanoparticles </li></ul><ul><ul><li>25 on a...
Occupational hygiene strategies by approach
Other factors <ul><li>Type and number of control measures mainly determined by the physical form </li></ul><ul><li>No diff...
Validation of risk assessement <ul><li>29 companies (78%): not supported by any exposure measurements </li></ul><ul><li>8 ...
Poor information exchange within the chain <ul><li>Information exchange on nanoparticles (from suppliers and to customers)...
Company policies for nanomaterials <ul><li>Defined by 9 companies (24%) </li></ul><ul><li>3 most important elements: </li>...
Conclusions <ul><li>Awareness of potential risk within companies </li></ul><ul><li>Companies try to do their best to cope ...
15.10.2008
Nano2Life 1953 Krebs Staudinger Zernike Citric acid Polymers Phase cycle Contrast Microscope Watson Description of...
 
of 17

Nanotechnology4 all 15.10.08

Presentation given in 2008 as a result of inventory how Nanotechnology is being handled in the Netherlands
Published on: Mar 3, 2016
Published in: Technology      
Source: www.slideshare.net


Transcripts - Nanotechnology4 all 15.10.08

  • 2. Survey on good practices in handling nanoparticles. - Survey in 37 companies in Netherlands- Paul Borm, Remko Houba, and Fenneke Linker.
  • 3. Current survey of use of Nanomaterials - study questions <ul><li>Use of nanomaterials in NL and number of exposed workers? </li></ul><ul><li>Measures to prevent exposure and risk (RI&E)? </li></ul><ul><li>Reasons for non-intervention? </li></ul><ul><li>Definition of best-practices? </li></ul><ul><li>Efficacy of best-practices and methods? </li></ul><ul><li>How to disseminate best-practices? </li></ul><ul><li>Exchange of data on toxicity of nanomaterials in the value chain? </li></ul><ul><li>Specific waste-management or recycling? </li></ul>
  • 4. 122 companies approached 60 companies relevant for survey 37 companies participated (62%) 49 no nanomaterials 8 no applications in NL 5 other 10 non-responders 6 convinced: ‘no risk’ 7 other
  • 6. Number of exposed workers <ul><li>37 companies </li></ul><ul><ul><li>41.000 employees </li></ul></ul><ul><ul><li>Currently approx. 400 exposed workers </li></ul></ul><ul><ul><ul><li>Total: 1% </li></ul></ul></ul><ul><ul><ul><li>Small companies: up to 35% </li></ul></ul></ul><ul><ul><ul><li>Large companies: 0.5% </li></ul></ul></ul>
  • 7. Main type of nanomaterials <ul><li>Nanosilver </li></ul><ul><li>Metal-oxides (Al, Fe, Ti, Sn, Zn, Sb, Ce) </li></ul><ul><li>Carbon black </li></ul><ul><li>Carbon nanotubes (CNT) </li></ul><ul><li>Clays </li></ul><ul><li>Silica, amorphous </li></ul><ul><li>Fullerenes (C 60 ) </li></ul><ul><li>Underlined: used in largest quantities (kg/tons) </li></ul>
  • 8. Risk assessment within companies <ul><li>34 (92%) specific risk-assessment for nanoparticles </li></ul><ul><ul><li>25 on application level (project) </li></ul></ul><ul><ul><ul><li>20 no risk with current control measures </li></ul></ul></ul><ul><ul><ul><li>5 risk assesment inconclusive yet </li></ul></ul></ul><ul><ul><li>9 on company level </li></ul></ul><ul><ul><ul><li>Specific company policy for nanomaterials (see later) </li></ul></ul></ul>
  • 9. Occupational hygiene strategies by approach
  • 10. Other factors <ul><li>Type and number of control measures mainly determined by the physical form </li></ul><ul><li>No differences: </li></ul><ul><ul><li>Type of company (research, private) </li></ul></ul><ul><ul><li>Amount of nanoparticles used </li></ul></ul><ul><ul><li>Size of the company </li></ul></ul>
  • 11. Validation of risk assessement <ul><li>29 companies (78%): not supported by any exposure measurements </li></ul><ul><li>8 companies (22%): some kind of exposure measurements: </li></ul><ul><ul><li>2 gravimetric only (nanoparticles?) </li></ul></ul><ul><ul><li>1 chemical analyses of specific component </li></ul></ul><ul><ul><li>5 meas. with condensation particle counter (CPC) and/or air sampling analyzed with SEM/TEM </li></ul></ul>
  • 12. Poor information exchange within the chain <ul><li>Information exchange on nanoparticles (from suppliers and to customers) </li></ul><ul><ul><li>19 (51%) no information exchange at all </li></ul></ul><ul><ul><li>18 (49%) at least some information exchange </li></ul></ul><ul><ul><ul><li>Only 7 (19%) active support by suppliers </li></ul></ul></ul><ul><ul><ul><li>Only 12 (32%) active communication to customers </li></ul></ul></ul>
  • 13. Company policies for nanomaterials <ul><li>Defined by 9 companies (24%) </li></ul><ul><li>3 most important elements: </li></ul><ul><ul><li>Pre-emptive choice on specific nanoparticles </li></ul></ul><ul><ul><li>Handling all nanomaterials as toxic substances (safety principle) </li></ul></ul><ul><ul><li>Choices on the physical form of nanoparticles </li></ul></ul>
  • 14. Conclusions <ul><li>Awareness of potential risk within companies </li></ul><ul><li>Companies try to do their best to cope with the problem </li></ul><ul><li>Safety strategy and control measures differ by company and highly depends on physical form </li></ul><ul><li>Validation of risk assessment is often lacking </li></ul><ul><li>Relevant information is often not available and not communicated within the chain </li></ul>
  • 15. 15.10.2008
  • 16. Nano2Life 1953 Krebs Staudinger Zernike Citric acid Polymers Phase cycle Contrast Microscope Watson Description of DNA structure (Nature 171:737) “ No chemistry”

Related Documents